Possible Differences in HCC Course Depending on DAA Treatment
Conditions: Carcinoma, Hepatocellular; Hepatitis C Virus Infection, Response to Therapy of; Drug Effect; Drug Side Effect; Hepatitis C, Chronic; Liver Cirrhosis Intervention: Drug: Direct Acting Antivirals Sponsor: Medical University of Warsaw Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver Cancer | Research